Search results for "letter"

showing 10 items of 4021 documents

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights

2019

medicine.medical_specialtyTazobactamLetterContinuous Renal Replacement Therapybusiness.industrymedicine.medical_treatmentCritical IllnessCEFTOLOZANE/TAZOBACTAMlcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RC86-88.9Critical Care and Intensive Care MedicineCephalosporinsmedicineHumansRenal replacement therapyIntensive care medicinebusinessCritical Care
researchProduct

Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy

2020

The coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, is creating an unprecedented global public health emergency with the continuous growth of infected individuals worldwide. Italy was one of the first European country to face the first wave of infection outside mainland China. The first case of COVID-19 was confirmed in Lombardy on February 20th , 2020, and subsequently, a rapid increase in the number of detected cases was observed, spreading through Italy and the rest of Europe.3 As of April 22nd , confirmed COVID-19 cases in Italy were 183,957.

medicine.medical_specialtyTildrakizumabBiolgical therapy; COVID-19; PsoriasisSettore MED/35PsoriasisChronic Disease; Emergencies; Humans; Italy; Psoriasis; Biological Therapy; COVID-19UstekinumabmedicineAdalimumabHumansPsoriasisbiologicsIntensive care medicineLetter to the Editorpsoriasipsoriasis; biologics; covid-19; pandemicEmergenciePsoriasiRisankizumabbusiness.industrySARS-CoV-2pandemicBiolgical therapyCOVID-19medicine.diseasedermatologyBiological TherapyIxekizumabGuselkumabInfectious Diseasescovid-19ItalyChronic DiseaseSecukinumabEmergenciesbusinessSettore MED/35 - MALATTIE CUTANEE E VENEREEbiologicCOVID-19 psoriasis biological therapiesmedicine.drugHuman
researchProduct

D-dimer testing: advantages and limitations in emergency medicine for managing acute venous thromboembolism

2007

Patients with suspected deep vein thrombosis (DVT) or pulmonary embolism (PE) are frequently admitted to an Emergency Department (ED) for initial evaluation. However, management of patients with suspicion of acute venous thromboembolism (VTE) in this clinical setting can be difficult; in fact symptoms and signs of DVT are non-specific and can be found in a broad spectrum of non-thrombotic disorders. An accurate and timely objective diagnosis is necessary for immediate and correct identification of patients with acute VTE, while avoiding the bleeding risk associated with unnecessary anticoagulant therapy in patients where DVT or PE have been ruled out. The diagnostic approach to patients wit…

medicine.medical_specialtyTime FactorsMEDLINEEnzyme-Linked Immunosorbent AssayEnglish languageDiseaseSensitivity and SpecificityFibrin Fibrinogen Degradation ProductsNephelometry and TurbidimetryD-dimermedicineInternal MedicineHumanscardiovascular diseasesProspective cohort studyLetters to the EditorIntensive care medicinePathologicalVenous ThrombosisPregnancybusiness.industryClinical judgementData synthesisEmergency departmentmedicine.diseasePulmonary embolismD-dimer emergency medicine venous thromboembolismVenous thrombosisAcute DiseaseEmergency medicineEmergency MedicineEmergenciesbusinessVenous thromboembolismAlgorithmsBlood samplingInternal and Emergency Medicine
researchProduct

Transcatheter embolization of a large aberrant systemic artery to an intralobar pulmonary sequestration using an Amplatzer vascular plug in an adoles…

2017

International audience

medicine.medical_specialtyTranscatheter embolizationVascular plug[SDV.IB.MN]Life Sciences [q-bio]/Bioengineering/Nuclear medicine030204 cardiovascular system & hematology[ SDV.IB.MN ] Life Sciences [q-bio]/Bioengineering/Nuclear medicinePulmonary sequestration03 medical and health sciences0302 clinical medicineText mining[INFO.INFO-IM]Computer Science [cs]/Medical ImagingmedicineRadiology Nuclear Medicine and imagingEndovascular treatment030212 general & internal medicineLetter to the EditorGeneralLiterature_REFERENCE(e.g.dictionariesencyclopediasglossaries)ComputingMilieux_MISCELLANEOUS[ INFO.INFO-IM ] Computer Science [cs]/Medical Imagingbusiness.industrymedicine.diseaseSurgerymedicine.anatomical_structureRadiologybusinessArtery
researchProduct

When to use frovatriptan in migraine? A reply

2011

Dear Sir, We read with interest the comments of Dr. Tfelt-Hansen [1] on the two recently published randomized controlled trials comparing patients’ preference (primary end-point) and efficacy (secondary end-points) of frovatriptan with respect to rizatriptan [2] and almotriptan [3]. In both studies, frovatriptan showed similar preference and short-term efficacy outcomes (pain relief and pain free episodes at 2 h) with respect to the other two triptans. The principal concern of Dr. Tfelt-Hansen was the very early use of frovatriptan in these studies, making their results hardly comparable with those of previous randomized controlled trials [4–6], where patients waited until the headache was …

medicine.medical_specialtybusiness.industryClinical NeurologyGeneral MedicineTriptansPlacebomedicine.diseaseRizatriptanlaw.inventionSumatriptanAnesthesiology and Pain MedicineRandomized controlled trialMigrainelawAlmotriptanInternal medicineMedicineMigraine Frovatriptan Almotriptan Patient preferenceNeurology (clinical)businessPsychiatryFrovatriptanLetter to the Editormedicine.drug
researchProduct

Suggested randomized, controlled trial for frovatriptan: a reply

2011

Dear Sir, We read with interest the comments of Dr. Tfelt-Hansen [1] regarding our three recently published randomized controlled trials comparing patients’ preference (primary endpoint) and efficacy (secondary endpoints) of frovatriptan 2.5 mg versus zolmitriptan 2.5 mg [2], rizatriptan 10 mg [3] and almotriptan 12.5 mg [4], and the meta-analysis of pooled individual data from the three studies [5]. In all studies frovatriptan showed similar preference and short-term efficacy outcomes (pain relief and pain-free episodes at 2 h) with respect to the other three triptans. The questions put by Dr. Tfelt-Hansen sound appropriate. Doubts are raised on the usefulness of head-to-head preference tr…

medicine.medical_specialtybusiness.industryClinical NeurologyZolmitriptanGeneral MedicineTriptansmedicine.diseaseRizatriptanEfficacySumatriptanAnesthesiology and Pain MedicineMigraineAlmotriptanmedicinefrovatriptan controlled trial migraineNeurology (clinical)Intensive care medicinebusinessFrovatriptanLetter to the Editormedicine.drugThe Journal of Headache and Pain
researchProduct

The comparison of effectiveness of therapy with ustekinumab and etanercept in psoriatic patients during 48 weeks' observation.

2021

medicine.medical_specialtybusiness.industryDermatologyRC31-1245DermatologyEtanerceptText miningRL1-803UstekinumabImmunology and AllergyMedicinebusinessInternal medicineLetter to the Editormedicine.drugPostepy dermatologii i alergologii
researchProduct

Hiatal herniation of the stomach and pancreas in a patient with oxygen desaturations

2013

Hiatal hernia (HH), a neglected cause of cardiorespiratory symptoms, is a frequent entity characterized by the displacement of the gastro- esophageal junction and part of the stomach into the mediastinum. Although often asymptomatic, HH may also exert a wide spectrum of clinical presentations due to cardio-pulmonary compression, including acute cardiovascular events such as arrhythmias, post-prandial syncope, angina-like chest pain, recurrent acute heart failure, hemodynamic collapse, electrocardiographic changes (T-wave inversion, ST elevation) simulating myocardial ischemia or pericarditis, and respiratory manifestations that can range from exercise intolerance and dyspnea on exertion to …

medicine.medical_specialtybusiness.industryST elevationGeneral MedicineExercise intolerancemedicine.diseaseChest painAsymptomaticPulmonary function testingHiatal hernia ;respiratory desaturation ; pancreas; pulmonary hypertensionHiatal herniaPericarditisHeart failureInternal medicineCardiologyMedicineMedicinecardiovascular diseasesmedicine.symptombusinessLetter to the EditorThe Libyan Journal of Medicine
researchProduct

Survival and causes of death in 2,033 patients with non-transfusion-dependent β-thalassemia

2021

medicine.medical_specialtybusiness.industryThalassemiabeta-ThalassemiaMEDLINEHematologymedicine.diseaseInternal medicineCause of DeathTransfusion dependencemedicineHumansBlood TransfusionBlood Transfusion; Cause of Death; Humans; beta-ThalassemiabusinessLetters to the EditorHaematologica
researchProduct

Bilateral Iatrogenic Femoral Neuropathy

2015

Dear Editor, Postoperative femoral neuropathy is an uncommon complication associated with pelvic/abdominal surgery. The main mechanism underlying this neuropathy is stretching and/or prolonged compression of the nerve.1,2 The nerve compression can be caused by the self-retaining retractors that are sometimes used during surgery directly constricting the nerve against the pelvic sidewall and inducing ischemia.1 Symptoms of femoral neuropathy are weakness of ipsilateral hip flexion and knee extension, and sensory deficit on the anteromedial thigh. The prognosis is generally good, with partial or complete recovery being common. Postoperative femoral neuropathy is generally unilateral2,3,4; bil…

medicine.medical_specialtybusiness.industryfemoral neuropathy - iatrogenic -HypoesthesiaThighmedicine.diseaseSurgeryRetractorLumbarPeripheral neuropathymedicine.anatomical_structureNeurologyFemoral nerveAnesthesiaMedicineSettore MED/26 - NeurologiaNeurology (clinical)Iliopsoasmedicine.symptombusinessLetter to the EditorAbdominal surgery
researchProduct